Merriman downgraded Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) after the company widened second quarter losses. The stock price tumbled 52 cents to $1.81.
Ariad Widens Losses
July 31, 2009 at 13:52 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.